Tessa Del Carmen1, Carrie Johnston2, Chelsie Burchett1, Eugenia L Siegler1. 1. Division of Geriatrics and Palliative Medicine, Weill Cornell Medicine, New York, NY, USA. 2. Division of Infectious Diseases, Weill Cornell Medicine/New York Presbyterian Hospital, New York, NY, USA.
Abstract
PURPOSE OF REVIEW: Antiretroviral therapy has enabled many people with HIV to live long lives with their infection, but the literature suggests that long term survivors are developing comorbidities and aging-related syndromes at earlier ages than their non-infected counterparts. In addition, there is evidence or sex-based differences in comorbidity risk. RECENT FINDINGS: How to best care for people aging with HIV is not known, but the tools of comprehensive geriatric assessment can identify people at risk for decline. Newer antiretroviral therapies offer promise of fewer side effects and drug interactions. We will also discuss special needs of women aging with HIV. SUMMARY: People with HIV and their providers are often unprepared to confront issues of aging, and each clinical program must develop methods to assess older patient and manage age-related complications and syndromes.
PURPOSE OF REVIEW: Antiretroviral therapy has enabled many people with HIV to live long lives with their infection, but the literature suggests that long term survivors are developing comorbidities and aging-related syndromes at earlier ages than their non-infected counterparts. In addition, there is evidence or sex-based differences in comorbidity risk. RECENT FINDINGS: How to best care for people aging with HIV is not known, but the tools of comprehensive geriatric assessment can identify people at risk for decline. Newer antiretroviral therapies offer promise of fewer side effects and drug interactions. We will also discuss special needs of women aging with HIV. SUMMARY: People with HIV and their providers are often unprepared to confront issues of aging, and each clinical program must develop methods to assess older patient and manage age-related complications and syndromes.
Authors: Silvia Nozza; Andrea Malagoli; Lilian Maia; Andrea Calcagno; Emanuele Focà; Giuseppe De Socio; Stefania Piconi; Giancarlo Orofino; Anna Maria Cattelan; Benedetto Maurizio Celesia; Elena Gervasi; Giovanni Guaraldi Journal: J Antimicrob Chemother Date: 2017-10-01 Impact factor: 5.790
Authors: Anne L Stangl; Valerie A Earnshaw; Carmen H Logie; Wim van Brakel; Leickness C Simbayi; Iman Barré; John F Dovidio Journal: BMC Med Date: 2019-02-15 Impact factor: 8.775